Myomo (MYO) EBT Margin Growth (5y) (2021 - 2025)
Myomo (MYO) EBT Margin Growth (5y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Myomo | 67.26 Mn | 48.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 10,910.00 |
| Jun 30, 2025 | 33,625.00 |
| Mar 31, 2025 | 34,321.00 |
| Dec 31, 2024 | 16,108.00 |
| Sep 30, 2024 | 45,004.00 |
| Jun 30, 2024 | 27,800.00 |
| Mar 31, 2024 | 21,302.00 |
| Dec 31, 2023 | 25,965.00 |
| Sep 30, 2023 | 40,572.00 |
| Jun 30, 2023 | 40,705.00 |
| Mar 31, 2023 | 69,177.00 |
| Dec 31, 2022 | 27,637.00 |
| Sep 30, 2022 | 22,700.00 |
| Jun 30, 2022 | 55,116.00 |
| Mar 31, 2022 | 58,739.00 |
| Dec 31, 2021 | 463,678.00 |
| Sep 30, 2021 | 46,058.00 |
| Jun 30, 2021 | 18,708.00 |